Hormone Drugs Up Asthma Risk
Hormone therapy and its side effects were the subject of a study reported in the Archives of Internal Medicine (February 23, 2004). The researchers discovered that postmenopausal women who used hormone therapy are at an increased risk for developing asthma, but not chronic obstructive pulmonary disease (COPD).
For this study, investigators at Brigham and Women's Hospital in Boston looked at data from the Nurses' Health Study. The participants in that study, which enrolled 121,700 married female registered nurses, aged 30 to 55, in 1976, were sent questionnaires once every 2 years. They were asked about their medical history, diet and lifestyle, exercise, and hormone use. During the years 1988 to 1996, the nurses were sent follow-up questionnaires that asked them about new asthma and COPD diagnoses.
The results indicated that current use of estrogen alone was connected with a 2.29 times greater risk of asthma.Women who used estrogen plus progestin had a similar increased rate of newly diagnosed asthma.
Articles in this issue
over 21 years ago
Article
Controlled-Release Paxil Is Effective and Well Tolerated for Social Anxiety DisorderNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025